The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Transcatheter treatment of multivalvular heart disease

DOI: 10.4244/EIJ-D-20-00244

1. Inselspital Universitatsspital Bern, Bern, Switzerland, Switzerland
2. Inselspital Universitätsspital Bern, Bern, Switzerland
Disclaimer:

As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers.

Please note that supplementary movies are not available online at this stage. Once a paper is published in its edited and formatted form, it will be accompanied online by any supplementary movies.

To read the full content of this article, please log in to download the PDF.

A 78-year old female patient with multivalvular heart disease and previous biventricular cardiac decompensation, was referred for treatment. Echocardiography revealed moderate-to-severe primary mitral regurgitation (MR) (vena contracta 7.5 mm) (Panel A), as well as secondary severe tricuspid regurgitation (TR) (VC 7.2 mm, hepatic systolic backflow). Left ventricular function was moderately impaired (LVEF 35%) with normal dimensions and no coronary artery disease. The right ventricle showed mild dilation and dysfunction. The EuroSCORE II of 4.3% was indicative of increased surgical risk, so that respecting the patient’s preference, a percutaneous approach was selected by the Heart Team. 

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic